WORLDSymposium™ 2020 Online Abstract Submission to Open July 1, 2019

The deadline for submitting an abstract to WORLDSymposium is October 1, 2019 for review by the Program Committee. Abstracts must be submitted with the intention that they will be presented if selected. First authors are expected to attend the meeting and make the presentation. Authors should not submit abstracts if they do not plan to attend the meeting. Click here for more information.

WORLDSymposium Registration Opens August 1, 2019

This symposium is designed for basic, translational and clinical researchers, patient advocacy groups, clinicians, and all others who are interested in learning more about the latest discoveries related to lysosomal diseases and the clinical investigation of these advances.

We’re Organizing Research on Lysosomal Diseases

Plan to attend the

16th Annual WORLDSymposium
February 10 – 13, 2020 in Orlando!

This symposium is designed for basic, translational and clinical researchers, patient advocacy groups, clinicians, and all others who are interested in learning more about the latest discoveries related to lysosomal diseases and the clinical investigation of these advances.

October 1, 2019
Deadline for abstract submission to WORLDSymposium 2020.

November 1 – December 1, 2019
Late breaking abstract submission open.

November 5, 2019
Notification of abstract acceptance for poster or platform presentation at WORLDSymposium 2020.

About WORLDSymposium

The goal of WORLDSymposium is to provide an interdisciplinary forum to explore and discuss specific areas of interest, research and clinical applicability related to lysosomal diseases. Each year, WORLDSymposium hosts a scientific meeting presenting the latest information from basic science, translational research, and clinical trials for lysosomal diseases. This symposium is designed to help researchers and clinicians to better manage and understand diagnostic options for patients with lysosomal diseases, identify areas requiring additional basic and clinical research, public policy and regulatory attention, and identify the latest findings in the natural history of lysosomal diseases.

Sign up for Updates

This symposium is designed for basic, translational and clinical researchers, patient advocacy groups, clinicians, and all others who are interested in learning more about the latest discoveries related to lysosomal diseases and the clinical investigation of these advances.

Recent Tweets

Phoenix Nest held it’s first kick off meeting at @WORLDSymposia PN’s KOL helped us lay out a plan of action to taking our IIID ERT to the clinic! A huge shout out and thanks for supporting PN. @PattiDickson #CUREmps 💜🦓💜

Plan to attend the

WORLDSymposium is a medical education conference focused on lysosomal diseases, which is wholly owned and operated by WORLDSymposia, Ltd. WORLDSymposium is independently managed by GMI, Inc. and Saterdalen & Associates, LLC. GMI and Saterdalen & Associates are independent entities, and are not partners, co-venturers or agents of WORLDSymposia, Ltd.

WORLDSymposium and the Lysosomal Disease Network (LDN) are separate and independent entities and are not affiliated in any way. WORLDSymposium receives NO FUNDING of any kind from the LDN, the National Institutes of Health (NIH), or any other federal agency.

The Lysosomal Disease Network (U54NS065768) is a part of the National Institutes of Health (NIH) Rare Diseases Clinical Research Network (RDCRN), supported through collaboration between the NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS), the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).